Stryker (SYK) stock
Last close $313.08 on 2026-11-19 (-1.59%) · Sector: Healthcare
Stryker is a large American medical technology company based in Kalamazoo, Michigan, that makes products used in hospitals and surgery, such as orthopedic implants, surgical equipment, and medical devices. It earns most of its money by selling these products to hospitals and healthcare providers around the world.
Stryker is still growing its sales, with revenue up 7.8% over the past year and a 20.6% operating margin, which means it keeps about 20 cents of profit from each dollar of sales before interest and taxes. The stock has returned -13.1% over the past year while the S&P 500 returned 9.7%, so it has lagged the broader market. Six insider sales totaling large dollar amounts were reported in the last 90 days and no insider buys, and the stock has tended to fall after earnings releases, dropping after three of the last four.
Key numbers
- Market cap: $120.4B
- Revenue (last 12 months): $26.30B
- Revenue growth: +7.8%
- Gross margin: 65.3%
- Operating margin: 20.6%
- P/E: 33.3
- P/S: 4.6
- Debt to equity: 0.60
- Current ratio: 2.18
Quality score
Overall 34/100 · growth 36 · profitability 45 · financial health 53 · value 0
Performance and risk
1-year return -13.1% vs S&P 500 +9.7% · volatility 32.7% (S&P 500 13.8%) · largest drop -30.4% · beta 0.24
Stock move the day after earnings
- 2026-01-29: +4.3%
- 2026-04-30: -6.5%
- 2026-07-30: -6.4%
- 2026-10-29: -6.4%
Congress trades (90 days)
3 buys, 1 sells
Insider trades (12 months)
Bought $0.0M · sold $579.8M
SYK stock research · SYK options calculator · Stocks to buy, hold or sell today
StrikeWright provides AI signals only, not financial advice.